Remotely Activated Protein-Producing Nanoparticles
Avi Schroeder(Technion – Israel Institute of Technology), Daniel G. Anderson(Massachusetts Institute of Technology), Róbert Langer(Massachusetts Institute of Technology), Sneha T. Kannan(Harvard–MIT Division of Health Sciences and Technology), Shan Jiang(Harvard–MIT Division of Health Sciences and Technology), Brian Joseph(Columbia University Irving Medical Center), Christopher G. Levins(Harvard–MIT Division of Health Sciences and Technology), Michael S. Goldberg(Jefferson Einstein Philadelphia Hospital), Yingxia Wang(Harvard–MIT Division of Health Sciences and Technology), Christian J. Kastrup(University of British Columbia)
Cited by 114
Related Papers
Transdermal drug delivery
|Nature Biotechnology|2008|3.4k
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
|Advanced Drug Delivery Reviews|2016|3.2k
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
Supramolecular biomaterials
|Nature Materials|2015|1.6k